ClinVar Genomic variation as it relates to human health
NM_000179.3(MSH6):c.628G>C (p.Val210Leu)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000179.3(MSH6):c.628G>C (p.Val210Leu)
Variation ID: 2709781 Accession: VCV002709781.1
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2p16.3 2: 47798611 (GRCh38) [ NCBI UCSC ] 2: 48025750 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 14, 2024 Feb 14, 2024 Jan 17, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000179.3:c.628G>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000170.1:p.Val210Leu missense NM_001281492.2:c.238G>C NP_001268421.1:p.Val80Leu missense NM_001281493.2:c.-279G>C 5 prime UTR NM_001281494.2:c.-275-4G>C intron variant NM_001406795.1:c.724G>C NP_001393724.1:p.Val242Leu missense NM_001406796.1:c.628G>C NP_001393725.1:p.Val210Leu missense NM_001406797.1:c.331G>C NP_001393726.1:p.Val111Leu missense NM_001406798.1:c.628G>C NP_001393727.1:p.Val210Leu missense NM_001406799.1:c.103G>C NP_001393728.1:p.Val35Leu missense NM_001406800.1:c.628G>C NP_001393729.1:p.Val210Leu missense NM_001406801.1:c.331G>C NP_001393730.1:p.Val111Leu missense NM_001406802.1:c.724G>C NP_001393731.1:p.Val242Leu missense NM_001406803.1:c.628G>C NP_001393732.1:p.Val210Leu missense NM_001406804.1:c.550G>C NP_001393733.1:p.Val184Leu missense NM_001406805.1:c.331G>C NP_001393734.1:p.Val111Leu missense NM_001406806.1:c.103G>C NP_001393735.1:p.Val35Leu missense NM_001406807.1:c.103G>C NP_001393736.1:p.Val35Leu missense NM_001406808.1:c.628G>C NP_001393737.1:p.Val210Leu missense NM_001406809.1:c.628G>C NP_001393738.1:p.Val210Leu missense NM_001406811.1:c.-279G>C 5 prime UTR NM_001406812.1:c.-279G>C 5 prime UTR NM_001406813.1:c.634G>C NP_001393742.1:p.Val212Leu missense NM_001406814.1:c.-279G>C 5 prime UTR NM_001406815.1:c.-279G>C 5 prime UTR NM_001406816.1:c.-279G>C 5 prime UTR NM_001406817.1:c.628G>C NP_001393746.1:p.Val210Leu missense NM_001406818.1:c.331G>C NP_001393747.1:p.Val111Leu missense NM_001406819.1:c.331G>C NP_001393748.1:p.Val111Leu missense NM_001406820.1:c.331G>C NP_001393749.1:p.Val111Leu missense NM_001406821.1:c.331G>C NP_001393750.1:p.Val111Leu missense NM_001406822.1:c.331G>C NP_001393751.1:p.Val111Leu missense NM_001406823.1:c.-279G>C 5 prime UTR NM_001406824.1:c.331G>C NP_001393753.1:p.Val111Leu missense NM_001406825.1:c.331G>C NP_001393754.1:p.Val111Leu missense NM_001406826.1:c.460G>C NP_001393755.1:p.Val154Leu missense NM_001406827.1:c.331G>C NP_001393756.1:p.Val111Leu missense NM_001406828.1:c.331G>C NP_001393757.1:p.Val111Leu missense NM_001406829.1:c.-279G>C 5 prime UTR NM_001406830.1:c.331G>C NP_001393759.1:p.Val111Leu missense NM_001407362.1:c.628-2055G>C intron variant NR_176257.1:n.717G>C non-coding transcript variant NR_176258.1:n.717G>C non-coding transcript variant NR_176259.1:n.717G>C non-coding transcript variant NR_176261.1:n.717G>C non-coding transcript variant NC_000002.12:g.47798611G>C NC_000002.11:g.48025750G>C NG_007111.1:g.20465G>C LRG_219:g.20465G>C LRG_219t1:c.628G>C LRG_219p1:p.Val210Leu - Protein change
- V212L, V35L, V80L, V111L, V210L, V242L, V184L, V154L
- Other names
- -
- Canonical SPDI
- NC_000002.12:47798610:G:C
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MSH6 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
9158 | 9474 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
Jan 17, 2024 | RCV003595080.3 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Jan 17, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary nonpolyposis colorectal neoplasms
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV004263635.1
First in ClinVar: Feb 14, 2024 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 210 of the MSH6 protein (p.Val210Leu). … (more)
This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 210 of the MSH6 protein (p.Val210Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with colon cancer (PMID: 28135145). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. | Yurgelun MB | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017 | PMID: 28135145 |
Text-mined citations for this variant ...
HelpRecord last updated Sep 30, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.